Related content

Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis

By Emad Yasser   Shehata Mohamed   Ragab Yasser   Saad Ahmed   Hamza Hosny   Abou-Zeid Alaa  

Modern Rheumatology, Vol. 20, Iss. 4, 2010-08 ,pp. : 358-365

Springer Publishing Company

Access to resources Recommend Favorite

The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis

By Xue Y.   Zhang J.   Chen Y-M.   Guan M.   Zheng S. G.   Zou H-J.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 3, 2008-01 ,pp. : 183-187

Informa Healthcare

Access to resources Recommend Favorite

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity

By Söderlin MK   Kastbom A   Kautiainen H   Leirisalo-Repo M   Strandberg G   Skogh T  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 3, 2004-05 ,pp. : 185-188

Informa Healthcare

Access to resources Recommend Favorite

Anti-cyclic citrullinated peptide antibodies do not reflect self-reported disability and physical health in patients with rheumatoid arthritis of less than 5 years of duration

By Poulsen Chalotte   Jacobsen Søren   Frisch Morten   Frederiksen Kirsten   Johansen Christoffer  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2763-2772

Springer Publishing Company

Access to resources Recommend Favorite